Inventor · disambiguated record
Yuuki Takaishi
Also filed as: TAKAISHI YUUKI
14 granted patents·15 pending applications·275 citations·filing 1998–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0195US6872405B2Quick-disintegrating tablet in buccal cavity and manufacturing method thereofYAMANOUCHI PHARMA CO LTD·Filed 2002·Granted Mar 29, 2005·72 cites·26 claims
- 0293US11707451B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2020·Granted Jul 25, 2023·3 cites·6 claims
- 0392US11839689B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Dec 12, 2023·2 cites·7 claims
- 0492US10842780B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2017·Granted Nov 24, 2020·6 cites·25 claims
- 0591US7255876B2Composition comprises sustained-release fine particles and manufacturing method thereofASTELLAS PHARMA INC·Filed 2002·Granted Aug 14, 2007·46 cites·20 claims
- 0689US12502357B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 0788US6328979B1Sustained release medicinal compositionsYAMANOUCHI PHARMACEUTICALS CO·Filed 1998·Granted Dec 11, 2001·90 cites·12 claims
- 0887US2025049721A1Formulations of EnzalutamideASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
- 0985US12059409B1Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2024·Granted Aug 13, 2024·0 cites·29 claims
- 1082US12447128B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·4 claims
- 1182US7575762B2Composition comprises sustained-release fine particles and manufacturing method thereofASTELLAS PHARMA INC·Filed 2007·Granted Aug 18, 2009·2 cites·8 claims
- 1278US6919372B1Sustained release pharmaceutical compositionsYAMANOUCHI PHARMA CO LTD·Filed 1998·Granted Jul 19, 2005·49 cites·10 claims
- 1374US8877214B2Pharmaceutical composition for modified releaseTAKAISHI YUUKI·Filed 2011·Granted Nov 4, 2014·5 cites·17 claims
- 1469US2016184275A2Pharmaceutical composition for modified useTAKAISHI YUUKI·Filed 2009·Application pending·0 cites
- 1568US2021322387A1Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2020·Application pending·0 cites
- 1667US12097189B1Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2024·Granted Sep 24, 2024·0 cites·30 claims
- 1767US2020060976A1Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2019·Application pending·0 cites
- 1865US12195661B2Liquid crystal polymer composition, liquid crystal polymer molded body, and camera moduleOTSUKA CHEMICAL CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·11 claims
- 1964US2019209476A1Formulations of enzalutamideMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 2063US2005100599A1Quick disintegrating tablet in buccal cavity and manufacturing method thereofYAMANOUCHI PHARMA CO LTD·Filed 2004·Application pending·0 cites
- 2162US2014378517A1Formulations of enzalutamideBEND RES·Filed 2014·Application pending·0 cites
- 2260US2017224624A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 2359US2014179749A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 2459US2014100256A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 2558US2017027910A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 2658US2015126565A1Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2014·Application pending·0 cites
- 2751US2005175689A1Coated fine particles containing drug for intrabuccally fast disintegrating tabletYAMANOUCHI PHARMA CO LTD·Filed 2004·Application pending·0 cites
- 2848US2004142043A1Sustained-release compositions for injection and process for producing the sameFiled 2002·Application pending·0 cites
- 2945US2012070465A1Pharmaceutical composition for modified releaseTAKAISHI YUUKI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuuki Takaishi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →